Suppr超能文献

磷酸盐选择对腺嘌呤诱导的慢性肾病小鼠模型的死亡率和血管钙化有影响。

Phosphate salt selection affects mortality and vascular calcification in the adenine-induced chronic kidney disease mouse model.

作者信息

Dargam Valentina, Ashbrook Sophie K, da Silva Nogueira Perony, Bakhshian Nik Amirala, Hutcheson Joshua D

机构信息

Department of Biomedical Engineering, Florida International University, Miami, Florida, United States.

Department of Biological Sciences, Florida International University, Miami, Florida, United States.

出版信息

Am J Physiol Heart Circ Physiol. 2025 Sep 1;329(3):H696-H704. doi: 10.1152/ajpheart.00534.2025. Epub 2025 Aug 13.

Abstract

Patients with chronic kidney disease (CKD) are at an increased risk for vascular calcification (VC), a strong predictor of cardiovascular events. Rodent models with elevated dietary levels of adenine and phosphate are commonly used to study CKD-induced VC; however, dietary composition, regimen duration, and reported outcomes vary widely across studies. Researchers customize high-adenine, high-phosphate (AdeHP) diets by adjusting phosphate levels and selecting specific phosphate salts as the phosphate source. In this observational study, we found that the selection and amount of phosphate salt used as the dietary phosphate source in an AdeHP mouse model of CKD-induced VC influence disease severity and survival in a sex-specific manner. Mice were fed a high-adenine diet for 6 wk to induce CKD, followed by an AdeHP diet containing either sodium (AdeHP-HNa) or calcium (AdeHP-HCa) based phosphate salts for up to six additional weeks to induce VC. Mice on the AdeHP-HCa diet exhibited worse kidney function and higher circulating phosphate levels compared with those on the AdeHP-HNa diet, with males showing more severe outcomes than females. However, mice on the AdeHP-HCa diet showed lower VC levels compared with those on the AdeHP-HNa diet, with males developing more calcification than females after 6 wk of the AdeHP regimen. Most importantly, a pronounced sex-dependent difference in survival was observed in males on the AdeHP-HNa diet, with only 16.67% surviving. These findings underscore the importance of phosphate salt selection and sex-specific variability in modeling CKD-induced VC with the AdeHP diet, providing key insights and considerations for preclinical studies. We identified that the type of phosphate salt used to increase dietary phosphate in the adenine-induced CKD mouse model of VC influences calcification severity, survival, renal function, and circulating phosphate levels in a sex- and time-specific manner, with males exhibiting more severe outcomes. These findings highlight the importance of selecting and reporting phosphate salts used to supplement custom-made diets to prevent animal mortality and effectively model CKD-induced VC.

摘要

慢性肾脏病(CKD)患者发生血管钙化(VC)的风险增加,而血管钙化是心血管事件的一个有力预测指标。饮食中腺嘌呤和磷酸盐水平升高的啮齿动物模型常用于研究CKD诱导的VC;然而,不同研究中的饮食组成、方案持续时间和报告的结果差异很大。研究人员通过调整磷酸盐水平并选择特定的磷酸盐作为磷源来定制高腺嘌呤、高磷酸盐(AdeHP)饮食。在这项观察性研究中,我们发现,在CKD诱导的VC的AdeHP小鼠模型中,用作饮食磷源的磷酸盐的选择和用量以性别特异性方式影响疾病严重程度和存活率。给小鼠喂食高腺嘌呤饮食6周以诱导CKD,随后再喂食含有钠基(AdeHP-HNa)或钙基(AdeHP-HCa)磷酸盐的AdeHP饮食长达6周以诱导VC。与AdeHP-HNa饮食组的小鼠相比,AdeHP-HCa饮食组的小鼠肾功能更差,循环磷酸盐水平更高,雄性小鼠的结果比雌性小鼠更严重。然而,与AdeHP-HNa饮食组的小鼠相比,AdeHP-HCa饮食组的小鼠VC水平更低,在AdeHP方案实施6周后,雄性小鼠的钙化程度比雌性小鼠更高。最重要的是,在AdeHP-HNa饮食组的雄性小鼠中观察到明显的性别依赖性生存差异,只有16.67%的小鼠存活。这些发现强调了在使用AdeHP饮食模拟CKD诱导的VC时,磷酸盐选择和性别特异性变异性的重要性,为临床前研究提供了关键的见解和考虑因素。我们确定,在腺嘌呤诱导的VC小鼠模型中,用于增加饮食中磷酸盐的磷酸盐类型以性别和时间特异性方式影响钙化严重程度、存活率、肾功能和循环磷酸盐水平,雄性小鼠的结果更严重。这些发现突出了选择和报告用于补充定制饮食的磷酸盐以防止动物死亡并有效模拟CKD诱导的VC的重要性。

相似文献

1
Phosphate salt selection affects mortality and vascular calcification in the adenine-induced chronic kidney disease mouse model.
Am J Physiol Heart Circ Physiol. 2025 Sep 1;329(3):H696-H704. doi: 10.1152/ajpheart.00534.2025. Epub 2025 Aug 13.
2
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Cochrane Database Syst Rev. 2025 Jun 27;6(6):CD006023. doi: 10.1002/14651858.CD006023.pub4.
4
Gut alterations in a chronic kidney disease rat model with diet-induced vascular calcification.
FEBS Open Bio. 2025 Aug;15(8):1219-1231. doi: 10.1002/2211-5463.70043. Epub 2025 Jun 17.
6
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3.
7
Altered dietary salt intake for preventing diabetic kidney disease and its progression.
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
9
Altered dietary salt intake for people with chronic kidney disease.
Cochrane Database Syst Rev. 2015 Feb 18(2):CD010070. doi: 10.1002/14651858.CD010070.pub2.
10
Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.
Cochrane Database Syst Rev. 2022 Aug 10;8(8):CD015207. doi: 10.1002/14651858.CD015207.

本文引用的文献

1
Non-Canonical TERT Activity Initiates Osteogenesis in Calcific Aortic Valve Disease.
Circ Res. 2025 Feb 14;136(4):403-421. doi: 10.1161/CIRCRESAHA.122.321889. Epub 2025 Jan 21.
4
Role of sphingolipid metabolism signaling in a novel mouse model of renal osteodystrophy based on transcriptomic approach.
Chin Med J (Engl). 2025 Jan 5;138(1):68-78. doi: 10.1097/CM9.0000000000003261. Epub 2024 Aug 16.
9
Effect of chronic kidney disease induced calcification on peripheral vascular perfusion using near-infrared spectroscopic imaging.
Biomed Opt Express. 2023 Dec 18;15(1):277-293. doi: 10.1364/BOE.503667. eCollection 2024 Jan 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验